Harvard Bioscience Inc (HBIO)

Harvard Bioscience, Inc. is a common stock listed on NASDAQ that represents equity in a life sciences tools and services company. The company develops, manufactures, and sells technologies, products, and related services for laboratory and research applications in the United States, Germany, and other international markets. Its portfolio includes cellular and molecular technology products such as infusion pumps, electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and equipment used in molecular testing and research. Harvard Bioscience also provides preclinical and physiological research tools, including telemetry systems, behavioral products, isolated organ and surgical products, respiratory testing solutions, inhalation and exposure systems, and data acquisition and analysis platforms. Its products are marketed to pharmaceutical and biotechnology companies, universities, hospitals, government laboratories, contract research organizations, and academic labs through sales teams, websites, and distributors. The company sells under brands including Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab. Founded in 1901, Harvard Bioscience is based in Holliston, Massachusetts.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.